• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

AZD1222 (Covishield) vaccination for COVID-19: Experiences, challenges, and solutions in Nepal.

作者信息

Sah Ranjit, Shrestha Sunil, Mehta Rachana, Sah Sohan Kumar, Rabaan Ali A, Dhama Kuldeep, Rodriguez-Morales Alfonso J

机构信息

Tribhuvan University Teaching Hospital, Institute of Medicine, Kathmandu, Nepal; National Public Health Laboratory, Kathmandu, Nepal.

Department of Pharmaceutical and Health Service Research, Nepal Health Research and Innovation Foundation, Lalitpur, Nepal.

出版信息

Travel Med Infect Dis. 2021 Mar-Apr;40:101989. doi: 10.1016/j.tmaid.2021.101989. Epub 2021 Feb 10.

DOI:10.1016/j.tmaid.2021.101989
PMID:33578045
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7872846/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9caa/7872846/2fd9396c6a4c/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9caa/7872846/2fd9396c6a4c/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9caa/7872846/2fd9396c6a4c/gr1_lrg.jpg

相似文献

1
AZD1222 (Covishield) vaccination for COVID-19: Experiences, challenges, and solutions in Nepal.用于新冠肺炎的阿斯利康新冠疫苗（Covishield）：尼泊尔的经验、挑战与解决方案
Travel Med Infect Dis. 2021 Mar-Apr;40:101989. doi: 10.1016/j.tmaid.2021.101989. Epub 2021 Feb 10.
2
Herpes simplex virus retinitis following ChAdOx1 nCoV- 19 (Covishield) vaccination for SARS CoV 2: A case report.接种 ChAdOx1 nCoV-19（Covishield）疫苗后出现单纯疱疹病毒视网膜炎：1 例报告。
Ocul Immunol Inflamm. 2022 Jul;30(5):1282-1285. doi: 10.1080/09273948.2022.2069127. Epub 2022 May 19.
3
Immune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOx1 nCov-19).接种新型冠状病毒疫苗（ChAdOx1 nCoV-19）后发生免疫性血小板减少性紫癜
Blood. 2021 Sep 16;138(11):996-999. doi: 10.1182/blood.2021012790.
4
Fertility rates and birth outcomes after ChAdOx1 nCoV-19 (AZD1222) vaccination.ChAdOx1 nCoV-19（AZD1222）疫苗接种后的生育率和出生结局
Lancet. 2021 Nov 6;398(10312):1683-1684. doi: 10.1016/S0140-6736(21)02282-0. Epub 2021 Oct 21.
5
Superficial venous thrombosisas a possible consequence of ChAdOx1 nCoV-19 vaccine: two case reports.腺病毒载体 ChAdOx1 nCoV-19 疫苗接种后引发浅静脉血栓形成：两例病例报告
J Med Case Rep. 2022 May 7;16(1):182. doi: 10.1186/s13256-022-03407-6.
6
Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data.异源初免-加强型新型冠状病毒肺炎疫苗接种：初始反应原性数据
Lancet. 2021 May 29;397(10289):2043-2046. doi: 10.1016/S0140-6736(21)01115-6. Epub 2021 May 12.
7
Thrombocytopenia after COVID-19 vaccination.新冠疫苗接种后的血小板减少症。
J Autoimmun. 2021 Sep;123:102712. doi: 10.1016/j.jaut.2021.102712. Epub 2021 Jul 27.
8
Cardiovascular Complication following Covishield Vaccination in Nepal: A Case Report.尼泊尔接种 Covishield 疫苗后的心血管并发症：一例报告。
JNMA J Nepal Med Assoc. 2021 Aug 12;59(240):805-807. doi: 10.31729/jnma.6454.
9
Comparison of neutralizing antibody responses against SARS-CoV-2 in healthy volunteers who received the BNT162b2 mRNA or the AZD1222 vaccine: Should the second AZD1222 vaccine dose be given earlier?接受BNT162b2 mRNA疫苗或AZD1222疫苗的健康志愿者中针对SARS-CoV-2的中和抗体反应比较：AZD1222疫苗的第二剂是否应提前接种？
Am J Hematol. 2021 Sep 1;96(9):E321-E324. doi: 10.1002/ajh.26248. Epub 2021 Jun 2.
10
Variants of concern responsible for SARS-CoV-2 vaccine breakthrough infections from India.引发 SARS-CoV-2 疫苗突破性感染的关注变体来自印度。
J Med Virol. 2022 Apr;94(4):1696-1700. doi: 10.1002/jmv.27461. Epub 2021 Nov 25.

引用本文的文献

1
Vaccine hesitancy in context of COVID-19 in East Africa: systematic review and meta-analysis.东非 COVID-19 背景下的疫苗犹豫：系统评价和荟萃分析。
BMC Public Health. 2024 Oct 12;24(1):2796. doi: 10.1186/s12889-024-20324-z.
2
COVID-19 vaccines breakthrough infection and adverse reactions in medical students: a nationwide survey in Iran.COVID-19 疫苗突破性感染与医学生不良反应：伊朗全国性调查
Front Public Health. 2024 Mar 13;12:1348015. doi: 10.3389/fpubh.2024.1348015. eCollection 2024.
3
Global Emergence of SARS-CoV2 Infection and Scientific Interventions to Contain its Spread.

本文引用的文献

1
Assessing COVID-19 vaccine literacy: a preliminary online survey.评估 COVID-19 疫苗知识：一项初步的在线调查。
Hum Vaccin Immunother. 2021 May 4;17(5):1304-1312. doi: 10.1080/21645515.2020.1829315. Epub 2020 Oct 29.
2
Evolution of the COVID-19 vaccine development landscape.新冠疫苗研发格局的演变。
Nat Rev Drug Discov. 2020 Oct;19(10):667-668. doi: 10.1038/d41573-020-00151-8.
3
An update on SARS-CoV-2/COVID-19 with particular reference to its clinical pathology, pathogenesis, immunopathology and mitigation strategies.
全球 SARS-CoV2 感染的出现及科学干预措施以遏制其传播。
Curr Protein Pept Sci. 2024;25(4):307-325. doi: 10.2174/0113892037274719231212044235.
4
A landscape on disorders following different COVID-19 vaccination: a systematic review of Iranian case reports.不同新冠病毒疫苗接种后疾病情况的综述：伊朗病例报告的系统评价
Eur J Med Res. 2023 Nov 26;28(1):542. doi: 10.1186/s40001-023-01531-7.
5
General publics' perception toward COVID-19 vaccines in Afghanistan, 2021.阿富汗民众对 COVID-19 疫苗的看法，2021 年。
Hum Vaccin Immunother. 2023 Aug 1;19(2):2228164. doi: 10.1080/21645515.2023.2228164. Epub 2023 Jul 7.
6
Knowledge and attitude toward COVID-19 booster dose among health care professionals in Nepal: a cross-sectional study.尼泊尔医护人员对新冠病毒加强针的认知与态度：一项横断面研究。
Ann Med Surg (Lond). 2023 Apr 4;85(4):772-777. doi: 10.1097/MS9.0000000000000434. eCollection 2023 Apr.
7
Post-vaccination Symptoms of Covishield Vaccine among Frontline Workers of a Tertiary Care Center in Pathanamthitta District.帕坦南蒂塔区一家三级护理中心一线工作人员接种Covishield疫苗后的症状
Indian J Community Med. 2023 Jan-Feb;48(1):61-64. doi: 10.4103/ijcm.ijcm_72_22. Epub 2022 Dec 8.
8
A 1-year analysis of adverse events following COVID-19 vaccination in Lebanon: a retrospective study.黎巴嫩新冠疫苗接种后不良事件的1年分析：一项回顾性研究。
J Pharm Policy Pract. 2023 Feb 21;16(1):24. doi: 10.1186/s40545-023-00528-1.
9
Omicron Variant of SARS-CoV-2: An Indian Perspective of Vaccination and Management.严重急性呼吸综合征冠状病毒2型奥密克戎变种：印度对疫苗接种及管理的看法
Vaccines (Basel). 2023 Jan 11;11(1):160. doi: 10.3390/vaccines11010160.
10
Are we expecting too much for too long from the vaccinators? A qualitative study on perceived challenges of COVID-19 vaccinators of district Shahdol, India.我们对疫苗接种人员的期望是否过高且持续时间过长？一项关于印度沙多尔地区新冠疫苗接种人员所面临挑战认知的定性研究。
J Family Med Prim Care. 2022 Oct;11(10):5940-5955. doi: 10.4103/jfmpc.jfmpc_148_22. Epub 2022 Oct 31.
SARS-CoV-2/COVID-19 的最新进展，特别参考其临床病理学、发病机制、免疫病理学和缓解策略。
Travel Med Infect Dis. 2020 Sep-Oct;37:101755. doi: 10.1016/j.tmaid.2020.101755. Epub 2020 May 30.